Cargando…

Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomas

Mechanistic target of rapamycin (mTOR) complex 1 is a central integrator of nutrient and growth factor inputs that controls cell growth in eukaryotes. The second generation of mTOR kinase inhibitors (TORKi), directly targeting the mTOR catalytic site, are more effective than rapamycin and its analog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bi, Chengfeng, Zhang, Xuan, Lu, Ting, Zhang, Xiaoyan, Wang, Xianhuo, Meng, Bin, Zhang, Huilai, Wang, Ping, Vose, Julie M., Chan, Wing C., McKeithan, Timothy W., Fu, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395116/ https://www.ncbi.nlm.nih.gov/pubmed/28104700 http://dx.doi.org/10.3324/haematol.2016.159160

Ejemplares similares

Multiple forms of tubulin in the cytoskeletal and flagellar microtubules of polytomella
por: McKeithan, TW, et al.
Publicado: (1981)

Gemcitabine, Navelbine, and Doxorubicin as Treatment for Patients with Refractory or Relapsed T-Cell Lymphoma
por: Qian, Zhengzi, et al.
Publicado: (2015)

Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57(CDKN1C) and TP53INP1 in mantle cell lymphoma
por: Li, Wei, et al.
Publicado: (2019)

Multiple forms of tubulin in polytomella and chlamydomonas: evidence for a precursor of flagellar α-tubulin
por: McKeithan, TW, et al.
Publicado: (1983)

PCR-based generation of shRNA libraries from cDNAs
por: Du, Cheng, et al.
Publicado: (2006)

Programmed Cell Death Protein 1/Programmed Cell Death Ligand-1 Axis activates Intracellular ERK Signaling in Tumor Cells to Mediate Poor Prognosis in T-cell Lymphoma
por: Li, Yang, et al.
Publicado: (2021)

Mechanistic Target of Rapamycin Pathway in Epileptic Disorders
por: Kim, Jang Keun, et al.
Publicado: (2019)

The mechanistic target for rapamycin pathway is related to the phosphorylation score for estrogen receptor-α in human breast tumors in vivo
por: Shrivastav, Anuraag, et al.
Publicado: (2014)

Haploinsufficiency of mechanistic target of rapamycin ameliorates bag3 cardiomyopathy in adult zebrafish
por: Ding, Yonghe, et al.
Publicado: (2019)

Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
por: Murray, James T., et al.
Publicado: (2018)

TonEBP modulates the protective effect of taurine in ischemia-induced cytotoxicity in cardiomyocytes
por: Yang, Y J, et al.
Publicado: (2015)

Amino acids and mechanistic target of rapamycin regulate the fate of live engulfed cells
por: Kim, Sung Eun, et al.
Publicado: (2021)

Targeting Translation Initiation by Synthetic Rocaglates for Treating MYC-driven Lymphomas
por: Zhang, Xuan, et al.
Publicado: (2019)

Assessment of T-cell receptor repertoire and clonal expansion in peripheral T-cell lymphoma using RNA-seq data
por: Gong, Qiang, et al.
Publicado: (2017)

A Phase I Trial to Evaluate the Multiple-Dose Safety and Antitumor Activity of Ursolic Acid Liposomes in Subjects with Advanced Solid Tumors
por: Qian, Zhengzi, et al.
Publicado: (2015)

Rac1 is a novel therapeutic target in mantle cell lymphoma
por: Tian, Tian, et al.
Publicado: (2018)

Phosphorylated 4EBP1 is associated with tumor progression and poor prognosis in Xp11.2 translocation renal cell carcinoma
por: Qu, Yuanyuan, et al.
Publicado: (2016)

Intrauterine growth retardation promotes fetal intestinal autophagy in rats via the mechanistic target of rapamycin pathway
por: WANG, Chao, et al.
Publicado: (2017)

Mechanistic target of rapamycin kinase (Mtor) is required for spermatogonial proliferation and differentiation in mice
por: Cao, Jun, et al.
Publicado: (2019)

Mechanistic/mammalian target of rapamycin and side effects of antipsychotics: insights into mechanisms and implications for therapy
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Sport-Related Concussion: Evaluation, Treatment, and Future Directions
por: McKeithan, Lydia, et al.
Publicado: (2019)

Mechanism of Activation of Mechanistic Target of Rapamycin Complex 1 by Methionine
por: Kitada, Munehiro, et al.
Publicado: (2020)

Mechanistic target of rapamycin inhibitors: successes and challenges as cancer therapeutics
por: Bhaoighill, Muireann Ní, et al.
Publicado: (2019)

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
por: Querfurth, Henry, et al.
Publicado: (2021)

A novel prognostic signature based on immune-related genes of diffuse large B-cell lymphoma
por: Wu, Zizheng, et al.
Publicado: (2021)

Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis
por: Zhang, Fen, et al.
Publicado: (2023)

Mechanistic Target of Rapamycin Complex 1/S6 Kinase 1 Signals Influence T Cell Activation Independently of Ribosomal Protein S6 Phosphorylation
por: Salmond, Robert J., et al.
Publicado: (2015)

Rapamycin and the transcription factor C/EBPβ as a switch in osteoclast differentiation: implications for lytic bone diseases
por: Smink, Jeske J., et al.
Publicado: (2009)

Mechanistic Target of Rapamycin (Mtor) Is Essential for Murine Embryonic Heart Development and Growth
por: Zhu, Yi, et al.
Publicado: (2013)

Enhanced activation of mechanistic target of rapamycin complex 1 signaling in eruptive xanthomas
por: Huang, Yan, et al.
Publicado: (2023)

Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
por: Qu, Zhenjie, et al.
Publicado: (2022)

p38β MAPK upregulates atrogin1/MAFbx by specific phosphorylation of C/EBPβ
por: Zhang, Guohua, et al.
Publicado: (2012)

Rapamycin inhibits spermatogenesis by changing the autophagy status through suppressing mechanistic target of rapamycin-p70S6 kinase in male rats
por: Liu, Shangjing, et al.
Publicado: (2017)

The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment
por: Maiese, Kenneth
Publicado: (2020)

Mechanistic target of rapamycin signaling in human nervous system development and disease
por: Girodengo, Marie, et al.
Publicado: (2022)

Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex
por: Lu, Yiyang, et al.
Publicado: (2020)

Mechanistic Target of Rapamycin Complex 1 Signaling Links Hypoxia to Increased IGFBP-1 Phosphorylation in Primary Human Decidualized Endometrial Stromal Cells
por: Nandi, Pinki, et al.
Publicado: (2021)

Feedback Activation of SGK3 and AKT Contributes to Rapamycin Resistance by Reactivating mTORC1/4EBP1 Axis via TSC2 in Breast Cancer
por: Wang, Hongtao, et al.
Publicado: (2019)

Human‐induced pluripotent stem cell‐derived cardiomyocytes: Cardiovascular properties and metabolism and pharmacokinetics of deuterated mexiletine analogs
por: Gomez‐Galeno, Jorge, et al.
Publicado: (2021)

Rapamycin improves Graves’ orbitopathy by suppressing CD4(+) cytotoxic T lymphocytes
por: Zhang, Meng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fpd5m6g1d8ldefe9lhnp96i24b